PodcastWall Street Wildlife Investing PodcastSeptember 25, 2026
Should You Buy Compass Pathways? The Magic Mushroom Stock No Analyst Will Touch $CMPS $RKLB $SHOP $PNG (E151)
Hosts discuss a Compass Pathways psilocybin investment case, the community portfolio picks (Kraken Robotics, Rocket Lab, Shopify), Treasury/gilt bonds and US debt risk, and a CyberArk acquisition brokerage mishap, with tangents on AI tools and personal life.
The full card is a free trial away.
The full summary and the deep dive on this episode, plus a brief every morning on the shows and companies you follow.
Read free — start your trial14-day free trial
Themes, sentiment and reasons are AI-written paraphrases, checked so they never quote an episode. They may contain errors. Not investment advice. Episodes remain the property of their creators.